Moreover, the severe ICD of cancer cells induced by our artificial RBCs can elicit systemic immune responses by releasing DAMPs and TAAs, which are further strengthened to effectively inhibit abscopal tumors in combination with Tim-3 blockade via triggering DC maturation, enhancing proinflammatory factor secretion, and promoting CD8+ T cell activation and infiltration. This evidence concerns the gene CD8A and cancer.